Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on November 5, 2026

3 hours ago

어레이패치 (ArrayPatch), 목표액 초과한 320만 유로 규모 시드 투자 유치 완료…차세대 마이크로니들 치료제 개발 가속화

Indeterminate GlobeNewswire

3 hours ago

ArrayPatch 完成超額認購的 320 萬歐元種子輪融資，加速新一代微針療法研發

Indeterminate GlobeNewswire

3 hours ago

ArrayPatch Memuktamadkan Pusingan Pembiayaan Benih €3.2 Juta yang Menerima Lebihan Langganan untuk Memajukan Terapeutik Mikroneedle Generasi Seterusnya

Indeterminate GlobeNewswire

3 hours ago

ArrayPatch 完成超额认购、金额达 320 万欧元的种子轮融资，推进新一代微针疗法

Indeterminate GlobeNewswire

4 hours ago

ArrayPatch Completes Oversubscribed €3.2 Million Seed Financing to Advance Next-Generation Microneedle Therapeutics

Indeterminate GlobeNewswire

4 hours ago

Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms

Indeterminate GlobeNewswire

4 hours ago

Ethris Reports Positive Topline Phase 2a Data for Nasal mRNA Candidate ETH47 in Asthma Patients Challenged with Rhinovirus

Indeterminate GlobeNewswire

5 hours ago

9M 2026: Novonesis delivered 7% organic sales growth, confirming full-year outlook

Indeterminate GlobeNewswire

5 hours ago

T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease

Indeterminate GlobeNewswire

5 hours ago

ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business

Indeterminate GlobeNewswire

6 hours ago

Molecular Partners to Present on DLL3-Targeting Radio-DARPin MP0712 at 2026 SNMMI Theranostics Conference and NACLC 2026

Indeterminate GlobeNewswire

6 hours ago

Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics

Indeterminate GlobeNewswire

11 hours ago

Cloudbreak Pharma Announces Top-Line Results from its Phase 3 Study of CBT-001 in Patients with Pterygium

Indeterminate GlobeNewswire

11 hours ago

Step Pharma to present data from ongoing phase 2 clinical trial of dencatistat in essential thrombocythaemia at 68th ASH Annual Meeting

Indeterminate GlobeNewswire

12 hours ago

Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar

Indeterminate GlobeNewswire

12 hours ago

MedVirtual Highlights the Human Advantage in Healthcare Staffing Amid the Rise of AI Alternatives

Indeterminate GlobeNewswire

12 hours ago

HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia

Indeterminate GlobeNewswire

12 hours ago

TaiMed Biologics to Present 24-Week Phase 2a Data on TMB-365/TMB-380 Maintenance Regimen at HIV Glasgow 2026

Indeterminate GlobeNewswire